Indian the largest sector for production of drugs was closed due to the spread of COVID-19. The pharmaceutical plants located in sector Baddi, Himachal Pradesh, forced to stop or significantly reduce the work as it was in the quarantine area, says FiercePharma.
It is known that the work stopped 50 pharmaceutical companies, including Sun Pharmaceuticals plant, a production site Dr. Reddy’s operates at 15% capacity, the plant of the Abbott – 25-30%, while Cadila – 35%.
Although these pharmaceutical companies also have factories in other parts of India and even in other countries, the possible impact of quarantine on the supply chain of drugs has attracted the attention of the FDA. Generic the US market is heavily dependent on the supply of medicines from China and India. To prevent shortages of drugs, the FDA has temporarily allowed hospitals to buy from pharmacy production of drugs intended for the treatment of patients with severe COVID-19.